- Home
- ATR vs ASND Comparison
ATR vs ASND Comparison
Compare ATR & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATR
- ASND
- Stock Information
- Founded
- ATR 1992
- ASND 2006
- Country
- ATR United States
- ASND Denmark
- Employees
- ATR N/A
- ASND N/A
- Industry
- ATR Plastic Products
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- ATR Industrials
- ASND Health Care
- Exchange
- ATR Nasdaq
- ASND Nasdaq
- Market Cap
- ATR 10.0B
- ASND 9.8B
- IPO Year
- ATR 1993
- ASND 2015
- Fundamental
- Price
- ATR $156.90
- ASND $175.69
- Analyst Decision
- ATR Strong Buy
- ASND Strong Buy
- Analyst Count
- ATR 4
- ASND 16
- Target Price
- ATR $180.00
- ASND $213.88
- AVG Volume (30 Days)
- ATR 309.0K
- ASND 456.2K
- Earning Date
- ATR 07-24-2025
- ASND 05-01-2025
- Dividend Yield
- ATR 1.15%
- ASND N/A
- EPS Growth
- ATR 17.39
- ASND N/A
- EPS
- ATR 5.47
- ASND N/A
- Revenue
- ATR $3,554,747,000.00
- ASND $398,509,511.00
- Revenue This Year
- ATR $4.27
- ASND $76.03
- Revenue Next Year
- ATR $5.25
- ASND $74.19
- P/E Ratio
- ATR $28.96
- ASND N/A
- Revenue Growth
- ATR 0.34
- ASND 12.06
- 52 Week Low
- ATR $130.85
- ASND $111.09
- 52 Week High
- ATR $178.03
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- ATR 57.51
- ASND 65.47
- Support Level
- ATR $154.26
- ASND $156.56
- Resistance Level
- ATR $158.78
- ASND $163.55
- Average True Range (ATR)
- ATR 2.26
- ASND 6.55
- MACD
- ATR -0.10
- ASND 0.99
- Stochastic Oscillator
- ATR 63.83
- ASND 91.68
About ATR AptarGroup Inc.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.